Evaxion - EBITDA 2020-2025 | EVAX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Evaxion - ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Evaxion - ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$46.1B
Doximity (DOCS)	$11.3B
Hims & Hers Health (HIMS)	$11.3B
Tempus AI (TEM)	$10.6B
IRhythm Technologies (IRTC)	$4.3B
Inspire Medical Systems (INSP)	$3.7B
Hinge Health (HNGE)	$3.7B
Privia Health (PRVA)	$2.4B
Schrodinger (SDGR)	$1.6B
Phreesia (PHR)	$1.5B
Enovis (ENOV)	$1.5B
Clover Health Investments (CLOV)	$1.5B
10x Genomics (TXG)	$1.5B
Azenta (AZTA)	$1.4B
Omnicell (OMCL)	$1.3B
Evolent Health (EVH)	$1.1B
Claritev (CTEV)	$702M
Fulgent Genetics (FLGT)	$541M
Veradigm (MDRX)	$531M
Standard BioTools (LAB)	$467M
Butterfly Network (BFLY)	$462M
Talkspace (TALK)	$415M
TruBridge (TBRG)	$336M
Outset Medical (OM)	$309M
Nyxoah SA (NYXH)	$280M
Health Catalyst (HCAT)	$254M
SOPHiA GENETICS SA (SOPH)	$248M
CapsoVision (CV)	$211M
Zepp Health (ZEPP)	$191M
KORU Medical Systems (KRMD)	$155M